From July 1, 2023 to September 30, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 1,575,692 shares, representing 4.52% for $11 million under the buyback announced on December 20, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.8 USD | -1.84% | -7.25% | -26.72% |
May. 13 | Transcript : Zevra Therapeutics, Inc. - Shareholder/Analyst Call | |
May. 08 | Earnings Flash (ZVRA) ZEVRA THERAPEUTICS Reports Q1 Revenue $3.4M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.72% | 201M | |
+9.85% | 74.45B | |
+11.35% | 9.18B | |
-12.85% | 5.02B | |
+60.16% | 5.03B | |
+1.60% | 3.82B | |
-19.20% | 2.41B | |
+18.65% | 2.39B | |
+24.62% | 2.26B | |
-27.46% | 2.27B |
- Stock Market
- Equities
- ZVRA Stock
- News Zevra Therapeutics, Inc.
- Tranche Update on Zevra Therapeutics, Inc.'s Equity Buyback Plan announced on December 20, 2021.